Global Sarcopenia Market to Grow at 2.36% CAGR to 2023, Predicts DelveInsight in Its New Research Report Now Available at MarketPublishers.com
17 Apr 2017 • by Natalie Aster
LONDON – Sarcopenia is known as the progressive loss of skeletal muscle associated with aging. After age 30 many people begin to lose modest amounts of muscles mass, further the loss of strength grows at an exponential rate alongside with aging. The development of Sarcopenia can be attributed to various contributory factors, including inadequate protein intake, surging splanchnic extraction of amino acids, lack of vitamin D, declined muscular response to postprandial anabolic stimuli, to name a few.
The world’s sarcopenia market is predicted to follow an upward trend, exhibiting a healthy 2.36% CAGR till 2023. By 2023, the number of registered cases of sarcopenia across the seven major markets is likely to cross 42.9 million.
New research report “Sarcopenia - Market Insights, Epidemiology and Market Forecast -2023-7 MM” drawn up by DelveInsight is an unrivalled source of information on the current state of the global sarcopenia market with a special focus on the 7 major markets (the USA, Japan, Germany, Spain, Italy, France and the UK). Moreover, the report identifies the market future prospects, highlights the emerging market trends, covers the key factors shaping the sarcopenia market, analyses the key market growth hinders and challenges. Moreover, the market covers the best opportunities and examines historical and present market performance in detail as well as gives future forecasts through 2023. Additionally, it includes historical and forecast epidemiological data for the prevalent cases of Sarcopenia.
To find other new comprehensive research reports by DelveInsight, please, follow to this page.